Autoimmune Diseases  >>  PD 360324  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
PD 360324 / Pfizer
NCT00550355: Dose-Escalating Multiple Dose Study of PD-0360324 in Combination With Methotrexate in Patients With Rheumatoid Arthritis

Completed
1
78
US, Europe, RoW
PD 0360324, Placebo
Pfizer
Arthritis, Rheumatoid
06/09
06/09
NCT01470313: A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus

Terminated
1
28
US, Canada, RoW
PD-0360324, Placebo
Pfizer
Cutaneous Lupus Erythematosus
11/13
11/13

Download Options